Paperpal Prime Logo

Multiple Sclerosis and Related Disorders : Impact Factor & More

eISSN: 2211-0356pISSN: 2211-0348

Key Metrics

CiteScore
5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
Scite Index
0.87 5-Year SI
SJR
Q3Neurology
SNIP
1.1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Multiple Sclerosis and Related Disorders

Multiple Sclerosis and Related Disorders Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER SCI LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Multiple Sclerosis and Related Disorders ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Multiple Sclerosis and Related Disorders

Tailoring disease-modifying therapy approaches across multiple sclerosis sub-populations.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Reliability and validity of the psychomotor vigilance task to quantify cognitive fatigability in multiple sclerosis.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
The many faces of the multiple sclerosis population in Canada.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Childhood trauma and treatment compliance in people with multiple sclerosis: The mediating role of physician-patient rapport.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Keeping cool - how persons with MS manage heat sensitivity: Insights from the Swiss multiple sclerosis registry.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Tailoring disease-modifying therapy approaches across multiple sclerosis sub-populations.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Reliability and validity of the psychomotor vigilance task to quantify cognitive fatigability in multiple sclerosis.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
The many faces of the multiple sclerosis population in Canada.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Childhood trauma and treatment compliance in people with multiple sclerosis: The mediating role of physician-patient rapport.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders
Keeping cool - how persons with MS manage heat sensitivity: Insights from the Swiss multiple sclerosis registry.
  • 1 Sep 2026
  • Multiple sclerosis and related disorders

FAQs on Multiple Sclerosis and Related Disorders